TCM
CRBU icon

Tradewinds Capital Management’s Caribou Biosciences CRBU Stock Holding History

Tradewinds Capital Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.41K Hold
800
– – ﹤0.01% 587
2026
Q1 		$1.52K Hold
800
– – ﹤0.01% 587
2025
Q4 		$1.27K Hold
800
– – ﹤0.01% 566
2025
Q3 		$1.86K Hold
800
– – ﹤0.01% 525
2025
Q2 		$1.01K Hold
800
– – ﹤0.01% 519
2025
Q1 		$731 Buy
+800
New +$1.04K ﹤0.01% 557

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Tradewinds Capital Management's CRBU Position: Q2 2026 in Review

Tradewinds Capital Management held its Caribou Biosciences (CRBU) position steady in Q2 2026 at 800 shares worth $1.41K. The position accounts for ﹤0.01% of the portfolio, ranked #587.

Tradewinds Capital Management first reported a position in CRBU in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.86K in Q3 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Tradewinds Capital Management held 800 shares of Caribou Biosciences worth $1.41K as of Q2 2026.
  • Tradewinds Capital Management left its Caribou Biosciences share count unchanged in Q2 2026.
  • Caribou Biosciences made up ﹤0.01% of Tradewinds Capital Management's portfolio in Q2 2026, its #587 holding.
  • Tradewinds Capital Management first reported a position in Caribou Biosciences in Q1 2025 and has held it in 6 quarters since.
  • Tradewinds Capital Management's Caribou Biosciences position peaked at $1.86K in Q3 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Tradewinds Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.